Your browser doesn't support javascript.
loading
Transferable data exclusivity vouchers are not the solution to the antimicrobial drug development crisis: a commentary on the proposed EU pharma regulation.
Berner-Rodoreda, Astrid; Cobelens, Frank; Vandamme, Anne-Mieke; Froeschl, Günter; Skordis, Jolene; Renganathan, Elil; t'Hoen, Ellen; Raviglione, Mario; Jahn, Albrecht; Bärnighausen, Till.
Afiliação
  • Berner-Rodoreda A; Heidelberg Institute of Global Health (HIGH), University Hospital, Heidelberg University, Heidelberg, Germany astrid.berner-rodoreda@uni-heidelberg.de.
  • Cobelens F; Amsterdam Institute for Global Health & Development (AIGHD) and Department of Global Health, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Vandamme AM; Clinical and Epidemiological Virology, Institute for the Future, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
  • Froeschl G; Center for Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisboa, Portugal.
  • Skordis J; Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, Munich, Germany.
  • Renganathan E; Institute for Global Health, University College London (UCL), London, UK.
  • t'Hoen E; School of Medical and Life Sciences, Sunway University, Bandar Sunway, Malaysia.
  • Raviglione M; Medicines Law & Policy, Amsterdam, The Netherlands.
  • Jahn A; Centre for Multidisciplinary Research in Health Science (MACH), University of Milan, Milano, Italy.
  • Bärnighausen T; Heidelberg Institute of Global Health (HIGH), University Hospital, Heidelberg University, Heidelberg, Germany.
BMJ Glob Health ; 9(2)2024 Feb 28.
Article em En | MEDLINE | ID: mdl-38423550

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anti-Infecciosos Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anti-Infecciosos Idioma: En Ano de publicação: 2024 Tipo de documento: Article